chitosan has been researched along with Glaucoma, Suspect in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abd-Elsalam, WH; ElKasabgy, NA | 1 |
Cheng, YH; Chiou, SH; Chiu, AW; Hung, KH; Ku, RY; Lee, CJ; Liu, CJ; Tsai, TH | 1 |
Li, J; Liu, D; Pan, H; Pan, W; Tan, G; Yang, X; Yu, S; Yuan, K | 1 |
3 other study(ies) available for chitosan and Glaucoma, Suspect
Article | Year |
---|---|
Mucoadhesive olaminosomes: A novel prolonged release nanocarrier of agomelatine for the treatment of ocular hypertension.
Topics: Acetamides; Adhesives; Administration, Ophthalmic; Amines; Animals; Biological Availability; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Hexoses; Intraocular Pressure; Male; Ocular Hypertension; Oleic Acid; Particle Size; Rabbits; Solubility | 2019 |
Sustained delivery of latanoprost by thermosensitive chitosan-gelatin-based hydrogel for controlling ocular hypertension.
Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Chitosan; Delayed-Action Preparations; Drug Evaluation, Preclinical; Gelatin; Humans; Hydrogels; Latanoprost; Male; Ocular Hypertension; Prostaglandins F, Synthetic; Rabbits; Triamcinolone Acetonide | 2014 |
Bioadhesive chitosan-loaded liposomes: A more efficient and higher permeable ocular delivery platform for timolol maleate.
Topics: Animals; Antihypertensive Agents; Chitosan; Drug Evaluation, Preclinical; Drug Liberation; Intraocular Pressure; Liposomes; Male; Ocular Hypertension; Particle Size; Permeability; Rabbits; Timolol; Tissue Distribution | 2017 |